Literature DB >> 3191924

Isolation and structural characterization of low-molecular-mass monosialyl oligosaccharides derived from respiratory-mucus glycoproteins of a patient suffering from bronchiectasis.

H Van Halbeek1, J Breg, J F Vliegenthart, A Klein, G Lamblin, P Roussel.   

Abstract

The carbohydrate chains of the respiratory-mucus glycoproteins of a patient suffering from bronchiectasis due to Kartagener's syndrome were released by alkaline borohydride treatment. Low-molecular-mass, monosialyl oligosaccharide-alditols were isolated by anion-exchange chromatography and fractionated by consecutive straight-phase high-performance liquid chromatography (HPLC) on a silica-based alkylamine column, and reverse-phase HPLC on a silica-based octadecyl column, respectively. The structures of the oligosaccharidealditols were determined by 500-MHz 1H-NMR spectroscopy in combination with sugar composition analysis. The 24 structures established range in size from disaccharides to heptasaccharides. Novel oligosaccharides obtained from the bronchiectasis mucus glycoproteins are: (formula; see text) 23 of the 24 monosialyl oligosaccharides characterized can be conceived of as extensions of neutral oligosaccharides purified from the bronchial mucus of this patient [Klein, A. et al. (1988) Eur. J. Biochem. 171, 631-642; Breg, J. et al. (1988) Eur. J Biochem. 171, 643-654]. The sialic acid residue was found to occur either in alpha (2----3)- or alpha (2----6)-linkage to a galactosyl residue or in alpha (2----6)-linkage to GalNAc-ol.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3191924     DOI: 10.1111/j.1432-1033.1988.tb14394.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  9 in total

1.  Evaluation of ion mobility-mass spectrometry for determining the isomeric heterogeneity of oligosaccharide-alditols derived from bovine submaxillary mucin.

Authors:  Hongli Li; Brad Bendiak; Kimberly Kaplan; Eric Davis; William F Siems; Herbert H Hill
Journal:  Int J Mass Spectrom       Date:  2013-10-15       Impact factor: 1.986

Review 2.  Human airway mucin glycosylation: a combinatory of carbohydrate determinants which vary in cystic fibrosis.

Authors:  G Lamblin; S Degroote; J M Perini; P Delmotte; A Scharfman; M Davril; J M Lo-Guidice; N Houdret; V Dumur; A Klein; P Rousse
Journal:  Glycoconj J       Date:  2001-09       Impact factor: 2.916

3.  Structure of two sulphated oligosaccharides from respiratory mucins of a patient suffering from cystic fibrosis. A fast-atom-bombardment m.s. and 1H-n.m.r. spectroscopic study.

Authors:  G Lamblin; H Rahmoune; J M Wieruszeski; M Lhermitte; G Strecker; P Roussel
Journal:  Biochem J       Date:  1991-04-01       Impact factor: 3.857

4.  Structures of sulfated oligosaccharides isolated from the respiratory mucins of a non-secretor (O, Le(a + b -)) patient suffering from chronic bronchitis.

Authors:  J M Lo-Guidice; H Herz; G Lamblin; Y Plancke; P Roussel; M Lhermitte
Journal:  Glycoconj J       Date:  1997-01       Impact factor: 2.916

5.  Different O-glycosylation of respiratory mucin glycopeptides from a patient with cystic fibrosis.

Authors:  K A Thomsson; I Carlstedt; N G Karlsson; H Karlsson; G C Hansson
Journal:  Glycoconj J       Date:  1998-08       Impact factor: 2.916

Review 6.  O-linked protein glycosylation structure and function.

Authors:  E F Hounsell; M J Davies; D V Renouf
Journal:  Glycoconj J       Date:  1996-02       Impact factor: 2.916

7.  Influence of TNFalpha on the sialylation of mucins produced by a transformed cell line MM-39 derived from human tracheal gland cells.

Authors:  P Delmotte; S Degroote; M D Merten; I Van Seuningen; A Bernigaud; C Figarella; P Roussel; J M Périni
Journal:  Glycoconj J       Date:  2001-06       Impact factor: 2.916

Review 8.  The role of airway mucus in pulmonary toxicology.

Authors:  J M Samet; P W Cheng
Journal:  Environ Health Perspect       Date:  1994-06       Impact factor: 9.031

9.  Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and InVitro Efficacy Analysis.

Authors:  Swetha Tati; John C Fisk; Julia Abdullah; Loukia Karacosta; Taylor Chrisikos; Padraic Philbin; Susan Morey; Diala Ghazal; Fatma Zazala; Joseph Jessee; Sally Quataert; Stephen Koury; David Moreno; Jing Ying Eng; Vladislav V Glinsky; Olga V Glinskii; Muctarr Sesay; Anthony W Gebhard; Karamveer Birthare; James R Olson; Kate Rittenhouse-Olson
Journal:  Neoplasia       Date:  2017-08-19       Impact factor: 5.715

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.